That reality is creating significant M&A logic in the sector, particularly around targets that already have credibility in protein, functional nutrition, digestive health, and portion-controlled premium formats, because acquiring a company that is already winning with the GLP-1 consumer compresses a timeline that organic innovation cannot
Avoid use in dogs with active cancer
Progress at your own pace, and at an intensity that makes you feel good
Compounders arent legally allowed to use the name brand in their marketing
The dose-dependent effect of GLP-1 on decelerating gastric emptying plays a substantial role in improving postprandial glycemic concentrations to the extent that postprandial insulin secretion may no longer be stimulated or could even be reduced (154, 155) ( Figure 1 Section D)
Book a 30-minute consultation